Please check your internet connection and try again.
## Overview
Diclofenac is a nonsteroidal anti-inflammatory drug (NSAID) used for pain and inflammation.
## Primary Indications
* Pain associated with osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis.
* Mild to moderate pain.
* Primary dysmenorrhea.
## Adult Dosing
* **Osteoarthritis, Rheumatoid Arthritis, Ankylosing Spondylitis:** 150 mg to 200 mg per day in divided doses. Maximum daily dose is 225 mg.
* **Mild to Moderate Pain/Primary Dysmenorrhea:**
* Initial dose: 50 mg three times daily as needed.
* Or: 100 mg as a single initial dose, followed by 50 mg doses as needed.
* Maximum daily dose: 200 mg.
## Pediatric Dosing
Dosing for children is not well-established and depends on the specific formulation and indication. Consult pediatric-specific resources.
## Dose Adjustments
* **Hepatic Impairment:** Use with caution. Lower doses may be warranted.
* **Renal Impairment:** Use with caution. Monitor renal function closely.
## Contraindications
* Hypersensitivity to diclofenac, aspirin, or other NSAIDs.
* History of asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs.
* Perioperative pain in the setting of coronary artery bypass graft (CABG) surgery.
## Adverse Effects
Common: Gastrointestinal upset, nausea, diarrhea, headache, dizziness.
Serious: Cardiovascular thrombotic events (MI, stroke), GI bleeding, ulceration, perforation, renal toxicity, hepatic injury, hypersensitivity reactions.
## Key Drug Interactions
* **Anticoagulants (e.g., warfarin):** Increased risk of bleeding.
* **Corticosteroids:** Increased risk of GI ulceration and bleeding.
* **ACE inhibitors, ARBs, Diuretics:** Reduced antihypertensive effect, increased risk of renal impairment.
* **Lithium:** Increased lithium levels.
* **Methotrexate:** Increased methotrexate toxicity.
## Monitoring
* **GI Bleeding/Ulceration:** Monitor for signs and symptoms.
* **Cardiovascular Risk:** Assess baseline and ongoing risk factors.
* **Renal Function:** Monitor BUN, creatinine, especially in patients with risk factors.
* **Hepatic Function:** Monitor LFTs, especially with prolonged use or pre-existing liver disease.
## Clinical Pearls
* Use the lowest effective dose for the shortest duration necessary to minimize risks.
* Administer with food or milk to reduce gastrointestinal upset.
* Consider gastroprotective agents (e.g., PPIs) for patients at high risk of GI complications.
* Be aware of the increased cardiovascular and GI risks associated with NSAIDs.
***
*This information is intended for healthcare professionals. Always consult the most current prescribing information and relevant clinical guidelines for complete and up-to-date details before making any clinical decisions.*